Breaking News
December 14, 2018 - New model could cure the potential to underestimate how quickly diseases spread
December 14, 2018 - Exercise-induced hormone activates cells critical for bone remodeling in mice
December 14, 2018 - Researchers discover new mechanism behind spread of malignant pleural mesothelioma
December 14, 2018 - Health Tip: Celebrate a Healthier Holiday
December 14, 2018 - Scalpel-free surgery enhances quality of life for Parkinson’s patients, study finds
December 14, 2018 - Early physical therapy can reduce risk, amount of long-term opioid use | News Center
December 14, 2018 - Genetic marker, predictor of early relapse in common childhood cancer discovered
December 14, 2018 - Study could lead to a potential new way of treating sepsis
December 14, 2018 - New protein complex helps embryonic stem cells to maintain their indefinite potential
December 14, 2018 - Salk professor receives $1.8 million from NOMIS Foundation for research on mechanisms to promote health
December 14, 2018 - New discovery will improve the safety and predictability of CRISPR
December 14, 2018 - Geneticists discover how sex-linked disorders arise
December 14, 2018 - New method to visualize small-molecule interactions inside cells
December 14, 2018 - Study describes mechanism that makes people more vulnerable to hunger-causing stimuli
December 14, 2018 - Chronic opioid therapy associated with increased healthcare spending and hospital stays
December 14, 2018 - Blood Types
December 14, 2018 - Obesity linked to increased risk of early-onset colorectal cancer
December 14, 2018 - Blood test helps identify distinct molecular signatures in children with cystic fibrosis
December 14, 2018 - Scientists use water to track electrical activity of nerve cells
December 14, 2018 - Recurrence of urinary tract infection may depend on bacterial strain, study shows
December 14, 2018 - GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
December 14, 2018 - Partial Thromboplastin Time (PTT) Test: MedlinePlus Lab Test Information
December 14, 2018 - Common tactics for health promotion at work may be detrimental to employees with obesity
December 14, 2018 - Myths about migration and health not supported by available evidence
December 14, 2018 - Recent findings on rare genetic disorder may help develop new treatment options
December 14, 2018 - New drug shows promise in treating sarcomas
December 14, 2018 - Scientists perform lung lavage as new approach for tuberculosis diagnosis in rhinoceros
December 14, 2018 - Recent winners of the Nobel Medicine Prize
December 14, 2018 - KHN’s ‘What the Health?’ Insurance enrollment is lagging — and there are lots of reasons why
December 14, 2018 - Study assesses safety and efficacy of new treatment for pancreatic cancer
December 14, 2018 - Study finds drug targets for Ebola, Dengue, and Zika viruses
December 14, 2018 - Shining new light on neuron firing
December 14, 2018 - Study highlights need for personalized approach to treat ICU acquired delirium
December 14, 2018 - Soot particles from road traffic significantly contribute to air pollution
December 14, 2018 - Massage helps relieve pain, improve mobility in patients with knee osteoarthritis
December 14, 2018 - Researchers explore home healthcare nurses’ knowledge attitudes toward infection control
December 14, 2018 - Average outpatient visit in the U.S. costs nearly $500, shows new study
December 14, 2018 - Reference Infliximab, Biosimilar Equivalent for Crohn’s Disease
December 14, 2018 - New contact lens to treat eye injuries
December 14, 2018 - Acne could have a genetic basis find researchers promising new cure
December 14, 2018 - Higher physical activity associated with improved mood
December 14, 2018 - New UGA study points to optimal hypertension treatment for stroke patients
December 14, 2018 - Study highlights factors that can reduce food cravings
December 14, 2018 - Researchers discover Ebola-fighting protein in human cells
December 14, 2018 - Fentanyl surpasses heroin in cause of U.S. drug overdose deaths
December 14, 2018 - When Heart Attack Strikes, Women Often Hesitate to Call for Help
December 14, 2018 - A warning about costume contacts
December 14, 2018 - Study examines link between peripheral artery disease and heart attack
December 14, 2018 - Researchers develop biotechnological tool to produce antifungal proteins in plants
December 14, 2018 - 3D-printed adaptive aids can benefit patients with arthritis
December 14, 2018 - Chronic bullying during adolescence impacts mental health
December 14, 2018 - Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics
December 13, 2018 - Importance of cell cycle and cellular senescence in the placenta discovered
December 13, 2018 - Gold “nanoprisms” open new window into vessels and single cells
December 13, 2018 - Research findings could lead to new targets for cancer-fighting therapeutics
December 13, 2018 - Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines
December 13, 2018 - Study explores how patients want to discuss symptoms with doctors
December 13, 2018 - RUDN medics first to gather scattered data on hepatitis morbidity in Somalia
December 13, 2018 - Age and gender disparities found in use of bed nets to prevent malaria in sub-Saharan Africa
December 13, 2018 - Caffeine therapy benefits developing brains of premature babies
December 13, 2018 - New review focuses on electrospinning techniques used in musculoskeletal tissue engineering
December 13, 2018 - A new division focused on human immune system
December 13, 2018 - Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of Fintepla (ZX008) in Dravet Syndrome
December 13, 2018 - BCR ABL Genetic Test: MedlinePlus Lab Test Information
December 13, 2018 - Caffeinated beverages during pregnancy linked to lower birth weight babies
December 13, 2018 - Stanford Medicine Health Trends Report examines opportunity to democratize health care
December 13, 2018 - Obsessive-compulsive disorder may protect individuals from obesity
December 13, 2018 - Scientists investigate how a painful event is processed in the brain
December 13, 2018 - Genetic study reveals new insights into underlying causes of moderate-to-severe asthma
December 13, 2018 - Study uncovers new genetic clues to frontotemporal dementia
December 13, 2018 - Vitamin C supplementation for pregnant smokers may reduce harm to infants’ lungs
December 13, 2018 - New study reveals yin-yang personality of dopamine
December 13, 2018 - Research identifies nerve-signaling pathway behind sustained pain after injury
December 13, 2018 - Children with high levels of callous traits show widespread differences in brain structure
December 13, 2018 - Long-term Benefit of Steroid Injections for Knee Osteoarthritis Challenged
December 13, 2018 - Adding new channels to the brain remote control
December 13, 2018 - In the Spotlight: A different side of neuroscience
December 13, 2018 - Medical Marvels: Using immunotherapy for melanoma that spread to the brain
December 13, 2018 - Puzzles do not keep dementia away finds study
December 13, 2018 - New mouse model shows potential for rapid identification of promising muscular dystrophy therapies
Preemies Fared Better When Parents Helped with NICU Care

Preemies Fared Better When Parents Helped with NICU Care

image_pdfDownload PDFimage_print

Action Points

  • Note that this cluster-randomized trial demonstrated that an intervention focusing on having family members provide direct care to NICU patients was associated with significant increases in infant weight gain.
  • Be aware that the intervention was quite time-intensive, requiring at least 6 hours of family presence 5 days a week.

Family Integrated Care, an intervention where parents helped provide support to their infants in the NICU, helped improved infant weight gain versus standard NICU care, Canadian researchers reported.

Infants randomized to Family Integrated Care (FICare) had a significantly greater weight gain at day 21 compared with infants receiving standard care (mean change in Z scores 1.58 versus 1.45, respectively, P<0.0001), according to Karel O'Brien, MB, of Sinai Health System in Toronto, and colleagues.

Moreover, parents in the FICare group had significantly lower mean stress scores (2.3 versus 2.5, respectively, P<0.00043) and anxiety scores (70.8 versus 74.2, respectively, P=0.0045), they wrote in the Lancet Child & Adolescent Health.

They noted that “care-by-parent” NICU models revealed such short-term benefits, such as improved infant weight gain, decreased nosocomial infection, fewer readmissions, and improved breastfeeding rates. Despite this research, “most [programs] do not integrate parents as part of the care team,” they said.

This multi-center trial randomized 18 tertiary NICUs from Canada, six from Australia, and one from New Zealand to either provide FICare or standard NICU care. Infants born ≤33 weeks gestation who had no or low-level respiratory support — defined as oxygen by cannula or mask or non-invasive ventilation such as continuous positive airway pressure, biphasic CPAP, and nasal intermittent pressure ventilation — were eligible to participate.

Families in the FICare sites had to commit to having a primary caregiver at the infant’s bedside for a minimum of 6 hours per day, 5 days a week, and to attend “medical rounds and education” for at least 3 weeks. They were then “encouraged to participate in care and orientated to the resources and tools available for education, charting and participation on rounds.” As part of the program, these parents bathed, fed, provided skin-to-skin care, dressed, changed diapers, and administered oral medications for their infants.

Overall, 13 NICUs provided FICare (one of 14 discontinued due to poor enrollment) and 12 provided standard care. There were 895 infants eligible for the FICare group and 891 eligible for the standard care group. Age of enrollment was similar between the two groups, although the authors noted that a larger portion of infants in the FICare group were born between 22 and 28 weeks versus the usual care group, and more parents in that group self-identified as Caucasian.

The difference in infant weight gain between the two groups was significant, even after adjusting for confounders, and the authors said that weight gain in the FICare group “increased faster and remained higher” during 21 days.

Parental stress scores were assessed via the Parental Stressor Scale: NICU and the State Trait Anxiety Inventory. Baseline scores between the two groups were similar, and both were lower on day 21, but the FICare group had significantly lower stress and anxiety scores versus the standard care group.

Rates of exclusive breastfeeding were also significantly higher in the FICare group, based on the rate of high-frequency breast milk feeds, defined as more than 6 times a day, compared with the standard care group (70% versus 63%, respectively, P=0.016).

But there were no differences between groups in rates of mortality, major morbidity, duration of oxygen therapy or duration of hospital stay, even after adjusting for confounders.

An accompanying editorial by Chris Gale, PhD, of Imperial College London sounded a couple of notes of caution, with the caveat that randomized trials must “identify and treat” comparison groups equally, based on the outcome of interest. He added that the FICare group required “considerable commitment,” and may have played a role in the results.

“The degree to which unmeasured confounders explain the differences seen in the study outcomes, rather than FICare per se, might be considerable, particularly in relation to parent-reported stress and anxiety,” Gale argued.

He also added that “it is not clear how [the primary outcome of weight gain after 21 days enrollment] relates to long-term measures of infant development or well-being, highlighting the importance of identifying core outcomes for neonatal trials that are important to stakeholders, including parents and ex-neonatal patients.”

O’Brien’s group noted limitations independent of the study design, such as increased rates of transfer of infants from FICare sites to level 2 NICUs before discharge home, and that there was less information about the status of infants in the FICare group than about infants in the standard care group upon discharge home. They also said they did not report the difference in weight gain at 36 weeks and at discharge home between infants in both groups because “some data were missing.”

The study was funded by the Canadian Institutes of Health Research (CIHR) Partnerships for Health System Improvement and the Ontario Ministry of Health and Long-Term Care.

O’Brien and one co-author disclosed grants from CIHR and Ontario Ministry of Health and Long-Term Care. One co-author disclosed a relevant relationship with the ALPHA Collaboration.

Gale disclosed a relevant relationship with the ALPHA Collaboration.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-08-02T00:00:00-0400

last updated

Tagged with:

About author

Related Articles